Bob S. Carter, MD, PhD, CEO of 麻豆学生精品版, was inducted into the National Academy of Medicine on October 18, 2025. Carter is a career neurosurgeon who serves as the A. Lorris Betz Executive Vice President for Health Sciences at the University of Utah.
Carter, who was elected to the Academy in October 2024, was among who were celebrated at the 2024 New Member Class Induction Ceremony in Washington, D.C. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Carter joins eight other University of Utah researchers who have been elected to the Academy.
鈥淭his honor for Dr. Bob Carter is a powerful recognition of his leadership and dedication to advancing medical science,鈥 Taylor Randall, University of Utah President says. 鈥淗is work exemplifies the spirit of innovation and service that defines the University of Utah, and we look forward to his continued impact in elevating patient care and shaping transformative research for years to come.鈥
Carter has made significant contributions to advancing personalized medicine through research, beginning with his MD/PhD studies with renowned molecular geneticist William B. Isaacs, PhD, at Johns Hopkins University. The two were integral to research characterizing prostate cancer as a heritable disease and later identified a genetic basis for the condition in the early 1990s. These discoveries laid the foundation for a field that has since advanced diagnosis and treatment of one of the most common cancers in men.
Carter鈥檚 ongoing commitment to creating new therapies for cancer was also evidenced in his efforts as one of the first physician-scientists to develop a novel cell-based immunotherapy against glioblastoma, an aggressive form of brain cancer. In this specialized CAR-T therapy, a patient鈥檚 immune cells are extracted, genetically modified, and reintroduced to fight their own cancer. Clinical trials are underway with encouraging preliminary findings.
As chair of the Department of Neurosurgery at Massachusetts General Hospital, Carter also led his department鈥檚 efforts to create novel personalized gene and cell-based therapies in other brain disorders. One project led by Carter and a team of collaborators was a 鈥榝irst in man鈥 approach to replace dopamine-producing brain cells lost in Parkinson鈥檚 disease by turning a patient鈥檚 own skin cells into these neurons and implanting them in the brain. The method has introduced new possibilities in personalized cell therapy, and this approach continues to be evaluated in clinical trials.
鈥淏ecoming a member of the National Academy of Medicine is a special recognition to me, as the academy emphasizes a vision for fostering impactful science and tackling our most significant human health challenges,鈥 Carter says. 鈥淚鈥檓 grateful for both the dedication and collaboration of many colleagues and mentors over the years, and also the wonderful commitment we share for advancing innovation to improve health.鈥
Prior to joining the University of Utah in 2025, Carter served as the William and Elizabeth Sweet Endowed Professor in Neuroscience at Harvard Medical School and鈥疦eurosurgeon-In-Chief at Massachusetts General Brigham. He received an MD and PhD in epidemiology from Johns Hopkins University and an undergraduate degree in chemistry from Brigham Young University.
As a member of the National Academy of Medicine, Carter will work alongside members of the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice to the nation while conducting other activities to solve complex problems and inform public policy decisions.
In addition to Carter, current or former University of Utah faculty elected to the National Academy of Medicine are: Baldomero Olivera, PhD; Mario Capecchi, PhD; Mary Beckerle, PhD; Vivian Lee, MD, PhD; Wendy Chapman, PhD; Sung Wan Kim, PhD; Paul D. Clayton, PhD; and Eli Y. Adashi, MD.